s-RT-MELT for rapid mutation scanning using enzymatic selection and real time DNA-melting:: new potential for multiplex genetic analysis

被引:18
作者
Li, Jin
Berbeco, Ross
Distel, Robert J.
Janne, Pasi A.
Wang, Lilin
Makrigiorgos, G. Mike [1 ]
机构
[1] Harvard Univ, Dept Radiat Oncol, Div Genom Stabil & DNA Repair, Dana Farber Brigham & Womens Canc Ctr,Sch Med, Boston, MA 02115 USA
[2] Harvard Univ, Translat Res Lab, Ctr Clin & Translat Res, Dana Farber Brigham & Womens Canc Ctr,Sch Med, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Lowe Ctr Thorac Oncol, Dana Farber Brigham & Womens Canc Ctr, Boston, MA 02115 USA
关键词
D O I
10.1093/nar/gkm403
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The rapidly growing understanding of human genetic pathways, including those that mediate cancer biology and drug response, leads to an increasing need for extensive and reliable mutation screening on a population or on a single patient basis. Here we describe s-RT-MELT, a novel technology that enables highly expanded enzymatic mutation scanning in human samples for germline or low-level somatic mutations, or for SNP discovery. GC-clamp-containing PCR products from interrogated and wild-type samples are hybridized to generate mismatches at the positions of mutations over one or multiple sequences in-parallel. Mismatches are converted to double-strand breaks using a DNA endonuclease (Surveyor (TM)) and oligonucleotide tails are enzymatically attached at the position of mutations. A novel application of PCR enables selective amplification of mutation-containing DNA fragments. Subsequently, melting curve analysis, on conventional or nano-technology real-time PCR platforms, detects the samples that contain mutations in a high-throughput and closed-tube manner. We apply s-RT-MELT in the screening of p53 and EGFR mutations in cell lines and clinical samples and demonstrate its advantages for rapid, multiplexed mutation scanning in cancer and for genetic variation screening in biology and medicine.
引用
收藏
页数:11
相关论文
共 46 条
[1]   Pyrosequencing: History, biochemistry and future [J].
Ahmadian, A ;
Ehn, M ;
Hober, S .
CLINICA CHIMICA ACTA, 2006, 363 (1-2) :83-94
[2]  
[Anonymous], 2005, Nat Methods, V2, P629
[3]   Targeting tyrosine kinases in cancer: The second wave [J].
Baselga, Jose .
SCIENCE, 2006, 312 (5777) :1175-1178
[4]  
Behn M, 1998, CLIN CANCER RES, V4, P361
[5]   Thermal stability of DNA [J].
Blake, RD ;
Delcourt, SG .
NUCLEIC ACIDS RESEARCH, 1998, 26 (14) :3323-3332
[6]   A comparison of high-resolution melting analysis with denaturing high-performance liquid chromatography for mutation scanning - Cystic fibrosis transmembrane conductance regulator gene as a model [J].
Chou, LS ;
Lyon, E ;
Wittwer, CT .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2005, 124 (03) :330-338
[7]  
COTTON RG, 1988, P NATL ACAD SCI USA, V83, P4397
[8]   Somatic mutations of the protein kinase gene family in human lung cancer [J].
Davies, H ;
Hunter, C ;
Smith, R ;
Stephens, P ;
Greenman, C ;
Bignell, G ;
Teague, B ;
Butler, A ;
Edkins, S ;
Stevens, C ;
Parker, A ;
O'Meara, S ;
Avis, T ;
Barthorpe, S ;
Brackenbury, L ;
Buck, G ;
Clements, B ;
Cole, J ;
Dicks, E ;
Edwards, K ;
Forbes, S ;
Gorton, M ;
Gray, K ;
Halliday, K ;
Harrison, R ;
Hills, K ;
Hinton, J ;
Jones, D ;
Kosmidou, V ;
Laman, R ;
Lugg, R ;
Menzies, A ;
Perry, J ;
Petty, R ;
Raine, K ;
Shepherd, R ;
Small, A ;
Solomon, H ;
Stephens, Y ;
Tofts, C ;
Varian, J ;
Webb, A ;
West, S ;
Widaa, S ;
Yates, A ;
Brasseur, F ;
Cooper, CS ;
Flanagan, AM ;
Green, A ;
Knowles, M .
CANCER RESEARCH, 2005, 65 (17) :7591-7595
[9]   Genetic mapping of thymine DNA glycosylase (Tdg) gene and of one pseudogene in the mouse [J].
DeGregorio, L ;
Gallinari, P ;
Gariboldi, M ;
Manenti, G ;
Pierotti, MA ;
Jiricny, J ;
Dragani, TA .
MAMMALIAN GENOME, 1996, 7 (12) :909-910
[10]   TILLING is an effective reverse genetics technique for Caenorhabditis elegans [J].
Gilchrist, Erin J. ;
O'Neil, Nigel J. ;
Rose, Ann M. ;
Zetka, Monique C. ;
Haughn, George W. .
BMC GENOMICS, 2006, 7 (1)